Australia markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
348.83+25.35 (+7.84%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close323.48
Open330.90
Bid348.75 x 1100
Ask348.90 x 800
Day's range325.17 - 349.41
52-week range54.21 - 349.41
Volume23,389,404
Avg. volume12,379,200
Market cap140.065B
Beta (5Y monthly)1.47
PE ratio (TTM)233.80
EPS (TTM)1.49
Earnings date05 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est184.92
  • Editor's pick
    Yahoo Finance Video

    Doctor on the Olympics regarding COVID-19: ‘There are a lot of concerns’

    Dr. Shikha Jain, Assistant Professor of Medicine, University of Illinois Chicago, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • This News May Hand the Vaccine Market Over to Pfizer and Moderna
    Motley Fool

    This News May Hand the Vaccine Market Over to Pfizer and Moderna

    It's fair to say that Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are dominating the coronavirus vaccine market these days. Their vaccines have fully immunized 86 million and 62 million Americans, respectively.

  • Why Moderna Stock Surged to a New All-Time High Today
    Motley Fool

    Why Moderna Stock Surged to a New All-Time High Today

    Shares of Moderna (NASDAQ: MRNA) jumped 7.8% to a record closing high of $348.83 on Friday after European health officials recommended authorizing the drugmaker's coronavirus vaccine for kids 12 and older. The European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion on Moderna's vaccine. The European Commission will now consider granting authorization for use in adolescents.